While life science venture capital funding declined 18.5 percent year-over-year to $20.8 billion in first half 2022, that level of funding is still greater than every full-year amount prior to 2018, according to a report released by Newmark, 2022 Mid-Year Life Science Overview & Market Clusters.
Life science fundraising activity increased, albeit at a slower pace, in first half 2022, with an estimated $46.9 billion raised since 2020. Venture capital as a whole has become more institutional and global in the past decade, making the